Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Indoco Remedies' Goa plant secures EU GMP certification from Malta regulator
Indoco Remedies has received EU GMP certification for its Goa manufacturing facility from the Malta Medicines Authority, bolstering its regulatory credentials in Europe and extending a series of recent compliance approvals across key production sites.
Indoco Remedies receives EU GMP certification for its Goa unit
From Malta Medicines Authority
PPAP Automotive Ltd leads gainers in 'B' group
Unichem Laboratories Ltd, Indoco Remedies Ltd, AVG Logistics Ltd and Motisons Jewellers Ltd are among the other gainers in the BSE's 'B' group today, 11 June 2026.
Indoco Remedies climbs after Baddi plant secures EU GMP certification; ICICI Prudential MF buys 1.47% stake
Indoco Remedies rose 4.04% to Rs 211.60 after the company said its oral solid dosage formulations facility at Baddi, Himachal Pradesh, received European Union Good Manufacturing Practice (EU GMP) certification from the German Health Authority (Berlin
Indoco Remedies gets EU GMP certification for Himachal Pradesh's Baddi OSD facility
On Wednesday (May 27), shares of Indoco Remedies Ltd ended at ₹202.90, up by ₹9.05, or 4.67%, on the BSE.
Indoco Remedies receives EU GMP certification from Malta Medicines Authority
The facility has received EU GMP certification from the Malta Medicines Authority confirming that it complies with the Good Manufacturing Practice requirements as referred in the EC Directive.
Indoco Remedies gains after reporting turnaround Q4 performance
Indoco Remedies surged 12.90% to Rs 257.35 after the company reported a standalone net profit of Rs 27.35 crore in Q4 FY26 compared with a net loss of Rs 26.24 crore in Q4 FY25.
Indoco Remedies Q4 Results: Loss halves, EBITDA returns to profit; shares rally 13%
Indoco Remedies narrowed its Q4 loss sharply as revenue rose 22% and EBITDA turned positive. Investor sentiment improved, with the stock surging over 13% in intraday trade following the earnings announcement.
Indoco Remedies reports consolidated net loss of Rs 21.64 crore in the March 2026 quarter
Sales rise 18.76% to Rs 455.90 crore
Indoco Remedies okays ₹110-cr slump sale of ophthalmic biz to Sunways India
The transaction covers the company’s ophthalmic division across India and select international territories, including Benin, Burkina Faso, Ivory Coast, Mali, Niger, Mauritania, Senegal, Cameroon, Congo, Gabon, Kenya, Botswana, Tanzania, Zambia, Zimbabwe and Namibia. Shares of Indoco Remedies Ltd ended at ₹209.05, down by ₹0.15, or 0.072%, on the BSE today, April 30.
Indoco Remedies testing unit clears FDA pre-approval inspection with zero observations
The inspection was conducted by the US Food and Drug Administration between April 8-10. Shares of Indoco Remedies Ltd ended at ₹209.95, up by ₹7.80, or 3.86%, on the BSE today, April 13.
Indoco Remedies in focus after Goa plant receives EU GMP certification
Indoco Remedies Share Price | The certification follows an inspection conducted by the regulator between November 19 and November 24, 2025.